Literature DB >> 21901842

Temporal and regional alterations in NMDA receptor expression in Mecp2-null mice.

Mary E Blue1, Walter E Kaufmann, Joseph Bressler, Charlotte Eyring, Cliona O'driscoll, Sakkubai Naidu, Michael V Johnston.   

Abstract

Our previous postmortem study of girls with Rett Syndrome (RTT), a development disorder caused by MECP2 mutations, found increases in the density of N-Methyl-D-aspartate (NMDA) receptors in the prefrontal cortex of 2-8-year-old girls, whereas girls older than 10 years had reductions in NMDA receptors compared with age-matched controls (Blue et al., Ann Neurol 1999b;45:541-545). Using [(3)H]-CGP to label NMDA-type glutamate receptors in 2- and 7-week old wild-type (WT), Mecp2-null, and Mecp2-heterozygous (HET) mice (Bird model), we found that frontal areas of the brain also exhibited a bimodal pattern in NMDA expression, with increased densities of NMDA receptors in Mecp2-null mice at 2 weeks of age but decreased densities at 7 weeks of age. Visual cortex showed a similar pattern, while other cortical regions only exhibited changes in NMDA receptor densities at 2 weeks (retrosplenial granular) or 7 weeks (somatosensory). In thalamus of null mice, NMDA receptors were increased at 2 and 7 weeks. No significant differences in density were found between HET and WT mice at both ages. Western blots for NMDAR1 expression in frontal brain showed higher levels of expression in Mecp2-null mice at 2 weeks of age but not at 1 or 7 weeks of age. Our mouse data support the notion that deficient MeCP2 function is the primary cause of the NMDA receptor changes we observed in RTT. Furthermore, the findings of regional and temporal differences in NMDA expression illustrate the importance of age and brain region in evaluating different genotypes of mice.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21901842      PMCID: PMC4122218          DOI: 10.1002/ar.21380

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  57 in total

Review 1.  Neurobiology of Rett syndrome.

Authors:  Michael V Johnston; Brendan Mullaney; Mary E Blue
Journal:  J Child Neurol       Date:  2003-10       Impact factor: 1.987

Review 2.  Paradoxical role of methyl-CpG-binding protein 2 in Rett syndrome.

Authors:  Janine M LaSalle
Journal:  Curr Top Dev Biol       Date:  2004       Impact factor: 4.897

3.  Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification.

Authors:  C Colantuoni; O H Jeon; K Hyder; A Chenchik; A H Khimani; V Narayanan; E P Hoffman; W E Kaufmann; S Naidu; J Pevsner
Journal:  Neurobiol Dis       Date:  2001-10       Impact factor: 5.996

4.  Annexin-1 is abnormally expressed in fragile X syndrome: two-dimensional electrophoresis study in lymphocytes.

Authors:  H T Sun; S Cohen; W E Kaufmann
Journal:  Am J Med Genet       Date:  2001-09-15

5.  Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3.

Authors:  Mona Shahbazian; Juan Young; Lisa Yuva-Paylor; Corinne Spencer; Barbara Antalffy; Jeffrey Noebels; Dawna Armstrong; Richard Paylor; Huda Zoghbi
Journal:  Neuron       Date:  2002-07-18       Impact factor: 17.173

6.  Methyl-CpG-binding protein 2 is localized in the postsynaptic compartment: an immunochemical study of subcellular fractions.

Authors:  K M Aber; P Nori; S M MacDonald; G Bibat; M H Jarrar; W E Kaufmann
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

7.  X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome.

Authors:  Juan I Young; Huda Y Zoghbi
Journal:  Am J Hum Genet       Date:  2004-02-17       Impact factor: 11.025

8.  Expression of MeCP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis.

Authors:  Deborah R S Cohen; Valéry Matarazzo; Amy M Palmer; Yajun Tu; Ok-Hee Jeon; Jonathan Pevsner; Gabriele V Ronnett
Journal:  Mol Cell Neurosci       Date:  2003-04       Impact factor: 4.314

9.  Olfactory biopsies demonstrate a defect in neuronal development in Rett's syndrome.

Authors:  Gabriele V Ronnett; Donald Leopold; Xiaohe Cai; Kristen C Hoffbuhr; Linda Moses; Eric P Hoffman; Sakkubai Naidu
Journal:  Ann Neurol       Date:  2003-08       Impact factor: 10.422

10.  Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain.

Authors:  B C Mullaney; M V Johnston; M E Blue
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

View more
  28 in total

Review 1.  Altered trajectories of neurodevelopment and behavior in mouse models of Rett syndrome.

Authors:  Elizabeth S Smith; Dani R Smith; Charlotte Eyring; Maria Braileanu; Karen S Smith-Connor; Yew Ei Tan; Amanda Y Fowler; Gloria E Hoffman; Michael V Johnston; Sujatha Kannan; Mary E Blue
Journal:  Neurobiol Learn Mem       Date:  2018-11-29       Impact factor: 2.877

2.  Mechanisms of Functional Hypoconnectivity in the Medial Prefrontal Cortex of Mecp2 Null Mice.

Authors:  Michael P Sceniak; Min Lang; Addison C Enomoto; C James Howell; Douglas J Hermes; David M Katz
Journal:  Cereb Cortex       Date:  2015-02-07       Impact factor: 5.357

3.  Cell-Specific Regulation of N-Methyl-D-Aspartate Receptor Maturation by Mecp2 in Cortical Circuits.

Authors:  Susanna B Mierau; Annarita Patrizi; Takao K Hensch; Michela Fagiolini
Journal:  Biol Psychiatry       Date:  2015-06-05       Impact factor: 13.382

4.  MeCP2 Modulates Sex Differences in the Postsynaptic Development of the Valproate Animal Model of Autism.

Authors:  Ki Chan Kim; Chang Soon Choi; Ji-Woon Kim; Seol-Heui Han; Jae Hoon Cheong; Jong Hoon Ryu; Chan Young Shin
Journal:  Mol Neurobiol       Date:  2014-11-18       Impact factor: 5.590

5.  Brain injury in canine models of cardiac surgery.

Authors:  Mary E Blue; Mary Ann Wilson; Claude A Beaty; Timothy J George; George J Arnaoutakis; Kara A Haggerty; Melissa Jones; Jeffrey Brawn; Shaliza Manmohan; Mary S Lange; Michael V Johnston; William A Baumgartner; Juan C Troncoso
Journal:  J Neuropathol Exp Neurol       Date:  2014-12       Impact factor: 3.685

Review 6.  Rett Syndrome: Reaching for Clinical Trials.

Authors:  Lucas Pozzo-Miller; Sandipan Pati; Alan K Percy
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

7.  Enhancement of postsynaptic GABAA and extrasynaptic NMDA receptor-mediated responses in the barrel cortex of Mecp2-null mice.

Authors:  Fu-Sun Lo; Mary E Blue; Reha S Erzurumlu
Journal:  J Neurophysiol       Date:  2015-12-16       Impact factor: 2.714

Review 8.  Abnormalities of the DNA methylation mark and its machinery: an emerging cause of neurologic dysfunction.

Authors:  Jacqueline Weissman; Sakkubai Naidu; Hans T Bjornsson
Journal:  Semin Neurol       Date:  2014-09-05       Impact factor: 3.420

9.  NMDA Receptors in the Central Nervous System.

Authors:  Kasper B Hansen; Feng Yi; Riley E Perszyk; Frank S Menniti; Stephen F Traynelis
Journal:  Methods Mol Biol       Date:  2017

10.  Preweaning sensorimotor deficits and adolescent hypersociability in Grin1 knockdown mice.

Authors:  Sheryl S Moy; Viktoriya D Nikolova; Natallia V Riddick; Lorinda K Baker; Beverly H Koller
Journal:  Dev Neurosci       Date:  2012-05-08       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.